01 4Sun Pharma Canada Inc.
01 22678749
02 22894869
01 4TILDRAKIZUMAB
01 4SOLUTION
01 11933-12-09
02 22028-02-21
03 12033-12-09
Patent Expiration Date : 2028-02-21
Date Granted : 2018-03-13
Brand Name : ILUMYA
Patent Number : 2678749
Filing Date : 2008-02-21
Strength per Unit : 100 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-02-21
Date Granted : 2018-03-13
Patent Expiration Date : 1933-12-09
Date Granted : 2021-06-15
Brand Name : ILUMYA
Patent Number : 2894869
Filing Date : 2013-12-09
Strength per Unit : 100 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1933-12-09
Date Granted : 2021-06-15
Patent Expiration Date : 2028-02-21
Date Granted : 2018-03-13
Brand Name : ILUMYA
Patent Number : 2678749
Filing Date : 2008-02-21
Strength per Unit : 100 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-02-21
Date Granted : 2018-03-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-12-09
Date Granted : 2021-06-15
Brand Name : ILUMYA
Patent Number : 2894869
Filing Date : 2013-12-09
Strength per Unit : 100 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2033-12-09
Date Granted : 2021-06-15
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
